Ivan V Lyagoskin

7PUBLICATIONS
21CO-AUTHORS
Molecular medicinePharmacogenomicsMolecular targetsAutonomic nervous systemCharacterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 26, 2026
Comparative Analysis of SMN2 Splicing Activity and Protein Production Following In Vitro Treatment with the Generic Risdiplam Drug Vapromin® and the Reference Drug Evrysdi®.

|Aug 26, 2026
An Open-Label, Comparative, Parallel Clinical Trial of the Safety, Pharmacokinetics and Immunogenicity of the Ustekinumab Biosimilar GNR-068 and the Originally Developed Ustekinumab as a Reference Drug After a Single Subcutaneous Administration in Healthy Male Volunteers.

|Jun 25, 2026
Development and Validation of Cell-Based Bioassay for the Detection of Neutralizing Antibodies to Ocrelizumab in Human Serum Using Antibody-Dependent Cell-Mediated Cytotoxicity Test in a Reporter Cell Line Expressing FcγRIIIa.

|Feb 27, 2026
Comparative Characterization of a Proposed Generic Nusinersen: Identity of the Oligonucleotide Structure and Equivalence in SMN2 Splicing Activity.

Serge Taran, Maksim Smolov, Maksim Degterev

|Feb 18, 2026
[Safety, tolerability, and pharmacokinetics of verenafusp alfa in healthy volunteers: results of an open-label multicohort phase I study].

E A Smolyarchuk, S S Sologova, A V Bushmanova

|Apr 04, 2023
Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome).

Valentina D Gusarova, Maxim A Smolov, Ivan V Lyagoskin

Pageof 2

Frequent Collaborators

7 joint publications

Rakhim Shukurov

4 joint publications

Ravil Khamitov

3 joint publications

Maxim A Smolov

3 joint publications

Maksim Degterev